[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"skill:01M7BXZATVDCAYZMDET0988S2K":3,"skill-same:01M7BXZATVDCAYZMDET0988S2K":107},{"skillNo":4,"name":5,"nameZh":6,"description":7,"descriptionZh":6,"repositoryFullName":8,"ownerLogin":9,"ownerAvatarUrl":10,"ownerAccountNo":11,"ownerDisplayName":12,"repositoryNo":13,"starsCount":14,"licenseSpdxId":15,"licenseFileUrl":6,"sourceHtmlUrl":16,"categories":17,"keywords":18,"publishedAt":19,"linkOnly":20,"markdownContent":21,"markdownBody":22,"frontMatter":23,"refName":41,"commitSha":42,"skillDirectory":43,"forksCount":14,"repositoryHtmlUrl":44,"repositoryHomepageUrl":6,"ownerHtmlUrl":45,"ownerBlogUrl":6,"ownerDescription":6,"updatedAt":46,"install":47,"resources":60},"01M7BXZATVDCAYZMDET0988S2K","clinical-research",null,"Use when designing a prospective clinical study before submission — selecting and classifying endpoints (primary \u002F key-secondary \u002F exploratory, with surrogate-endpoint flagging), estimating sample size and power for two-arm designs (means \u002F proportions \u002F survival), or scoring a study plan for feasibility and a GO \u002F GO-WITH-CONDITIONS \u002F REDESIGN \u002F NO-GO phase-gate decision. Every output is an ESTIMATE plus a named human owner (clinician \u002F biostatistician \u002F regulatory owner) — never clinical fact, never a finished protocol. Distinct from ra-qm-team, which handles the regulatory\u002FQM submission (ISO 13485, EU MDR, FDA 510(k)\u002FPMA\u002FQSR), not the study design.","azhri1990\u002Fproject-genesis","azhri1990","https:\u002F\u002Favatars.githubusercontent.com\u002Fu\u002F281207543?v=4","01M7BMC0WHXB2ZA9SH1PFJDYNS","Nashriq Mokhtar","01M7BMC0XAE6SV0VTKWP3EMFGZ",0,"MIT","https:\u002F\u002Fgithub.com\u002Fazhri1990\u002Fproject-genesis\u002Fblob\u002Fmain\u002Fclaude-skills\u002F.vibe\u002Fskills\u002Fclaude-skills\u002Fresearch-ops\u002Fclinical-research\u002FSKILL.md",[],[],"2026-11-15 14:19:17",false,"---\nname: clinical-research\ndescription: Use when designing a prospective clinical study before submission — selecting and classifying endpoints (primary \u002F key-secondary \u002F exploratory, with surrogate-endpoint flagging), estimating sample size and power for two-arm designs (means \u002F proportions \u002F survival), or scoring a study plan for feasibility and a GO \u002F GO-WITH-CONDITIONS \u002F REDESIGN \u002F NO-GO phase-gate decision. Every output is an ESTIMATE plus a named human owner (clinician \u002F biostatistician \u002F regulatory owner) — never clinical fact, never a finished protocol. Distinct from ra-qm-team, which handles the regulatory\u002FQM submission (ISO 13485, EU MDR, FDA 510(k)\u002FPMA\u002FQSR), not the study design.\nversion: 2.9.0\nauthor: claude-code-skills\nlicense: MIT\ntags: [research-ops, clinical-research, study-design, endpoint, sample-size, power, phase-gate, biostatistics]\ncompatible_tools: [claude-code, codex-cli, cursor, antigravity, opencode, gemini-cli]\n---\n\n# clinical-research\n\nProspective clinical study DESIGN: endpoints, sample size \u002F power, and phase-gate feasibility. Every output is an **estimate with stated assumptions** routed to a **named human owner**. This skill never gives clinical advice as fact and never substitutes for a biostatistician or regulatory affairs.\n\n## Purpose\n\nR&D clinical teams, medical monitors, and biostatistics functions live at the moment between *we-have-a-hypothesis* and *we-have-a-protocol-ready-for-submission*. This skill structures three of the hardest design decisions:\n\nThree deterministic tools:\n\n1. `sample_size_estimator.py` — Closed-form power \u002F sample-size for two-arm **means** (Cohen's d), **proportions** (normal approximation), and **survival** (Schoenfeld events). Inflates for dropout. Prints an \"ESTIMATE — confirm with a biostatistician\" banner.\n2. `endpoint_selector.py` — Scores candidate endpoints across 5 weighted dimensions (clinical relevance, measurability, regulatory acceptance, sensitivity-to-change, burden) and classifies each as **PRIMARY \u002F KEY-SECONDARY \u002F EXPLORATORY**. Penalizes unvalidated surrogate endpoints.\n3. `phase_gate_scorer.py` — Scores a study plan 0-100 across recruitment feasibility, endpoint readiness, statistical power, operational complexity, and budget fit; returns **GO \u002F GO-WITH-CONDITIONS \u002F REDESIGN \u002F NO-GO** plus the named owners who must sign.\n\n## When to use\n\nInvoke this skill when:\n\n- You are choosing a primary endpoint and need to defend it against surrogate-endpoint scrutiny.\n- You need a defensible first sample-size estimate for a protocol synopsis.\n- A study plan needs a feasibility read before a phase-gate review.\n- You are pressure-testing whether the planned enrollment is achievable given the eligible population and sites.\n\n**Do NOT use this skill to**: prepare a regulatory submission or clinical evaluation report (use `ra-qm-team`), find or position a grant (use `research\u002Fgrants`), design a live product A\u002FB experiment (use `product-team\u002Fexperiment-designer`), or replace a biostatistician's final sample-size justification.\n\n## Workflow\n\n1. **Draft the synopsis** — Fill `assets\u002Fprotocol_synopsis_template.md` (objectives, design, population, endpoints, statistical plan placeholder, owners-to-sign).\n2. **Select the endpoint** — Run `endpoint_selector.py --input endpoints.json --profile {drug|device|biologic|diagnostic|digital-therapeutic}`. Read the classification + surrogate flags. If >1 primary, plan multiplicity control.\n3. **Estimate the sample size** — Run `sample_size_estimator.py --design {means|proportions|survival} ...`. Trace the effect\u002Fdifference\u002FHR to a published or anchor-based source; inflate for dropout.\n4. **Score feasibility** — Run `phase_gate_scorer.py --input study.json --profile \u003Csame> --phase {1|2|3|4}`. Read the verdict + blockers + named owners.\n5. **Route for sign-off** — Assemble the synopsis + estimates into the gate packet. The packet is **a recommendation**; a biostatistician, medical monitor, and regulatory owner sign.\n\n## Scripts\n\n| Script | Purpose | Profiles |\n|---|---|---|\n| `scripts\u002Fsample_size_estimator.py` | Power \u002F sample-size for means, proportions, survival | n\u002Fa (design-driven) |\n| `scripts\u002Fendpoint_selector.py` | 5-dimension endpoint scoring + classification + surrogate flag | drug, device, biologic, diagnostic, digital-therapeutic |\n| `scripts\u002Fphase_gate_scorer.py` | Feasibility 0-100 + GO\u002FGO-WITH-CONDITIONS\u002FREDESIGN\u002FNO-GO + owners | drug, device, biologic, diagnostic, digital-therapeutic |\n\nAll three: stdlib-only, `--help`, `--sample`, `--output {human,json}`.\n\n## Onboarding & customization\n\nRun the onboarding questionnaire **once before you start** — it captures your defaults and named owners so every tool in this skill is pre-configured. Customization is the point: the answers actually change tool behavior.\n\n```bash\npython3 scripts\u002Fonboard.py            # interactive (also: --defaults, --set key=value, --reset)\npython3 scripts\u002Fonboard.py --show     # see the questions + current effective config\n```\n\nAnswers are saved to `~\u002F.config\u002Fresearch-ops\u002Fclinical-research.json` (global) or `.\u002F.research-ops\u002Fclinical-research.json` (`--scope project`) and are read automatically by `config_loader.py`. They set the default development-area **profile**, default **alpha \u002F power \u002F dropout**, and the named **biostatistician \u002F medical monitor \u002F regulatory owner** printed on outputs. CLI flags always override saved config; `RESEARCH_OPS_NO_CONFIG=1` ignores it entirely.\n\n**The seven questions:** development area · alpha · power · dropout · biostatistician · medical monitor · regulatory owner.\n\n## Optimize with autoresearch (opt-in)\n\nThis skill ships an **isolated, opt-in** bridge to `engineering\u002Fautoresearch-agent`. Only when you ask to \"optimize\" \u002F \"run a loop\" does an autoresearch experiment iteratively improve a study plan against this skill's own feasibility score. `scripts\u002Far_evaluator.py` is the ground-truth evaluator; it prints `feasibility_composite: \u003C0-100>` (higher is better).\n\n```bash\n\u002Far:setup --domain custom --name trial-feasibility \\\n  --target study.json \\\n  --eval \"python3 ar_evaluator.py --target study.json\" \\\n  --metric feasibility_composite --direction higher\n\u002Far:loop custom\u002Ftrial-feasibility\n```\n\nIsolated: no hard dependency — autoresearch runs only on demand, and the loop edits `study.json`, never the evaluator (locked ground truth).\n\n## References\n\n- `references\u002Fstudy_design_canon.md` — ICH E8(R1) general considerations; ICH E9 + E9(R1) estimand addendum; CONSORT 2010; SPIRIT 2013; FDA Multiple Endpoints guidance (2022).\n- `references\u002Fendpoint_and_power.md` — Cohen *Statistical Power Analysis*; Schoenfeld (1983) survival sample size; FDA Surrogate Endpoint Table \u002F BEST glossary; FDA PRO guidance (2009); Chow, Shao & Wang *Sample Size Calculations in Clinical Research*.\n- `references\u002Ftrial_operations.md` — ICH E6(R2\u002FR3) GCP; TransCelerate risk-based monitoring; FDA RBM guidance; CTTI recruitment best practices; site-feasibility scoring literature.\n\n## Assumptions\n\n- Sample-size formulas use normal approximations with a built-in z-table. They are first-pass **estimates**; a biostatistician produces the final justification (and may use simulation, adaptive designs, or exact methods).\n- The endpoint scorer applies *customary* regulatory priors per development area via `--profile`. Company- or indication-specific precedent overrides the prior.\n- The phase-gate scorer bakes in a profile cost-per-patient benchmark; pass a real budget to override the default.\n- An unvalidated surrogate cannot anchor a PRIMARY endpoint — the scorer enforces this with a penalty.\n\n## Anti-patterns\n\n- **Presenting a power estimate as fact.** Every output is an estimate with a named owner who must sign.\n- **Powering for a convenience effect size.** The effect must trace to a published or anchor-based MCID, not to the n you can afford.\n- **Anchoring a primary on an unvalidated surrogate.** Surrogate endpoints need validation evidence for the indication.\n- **Ignoring multiplicity.** More than one primary endpoint requires pre-specified alpha allocation.\n- **Skipping dropout inflation.** Raw n undersizes the study; inflate by 1\u002F(1 − dropout).\n\n## Distinct from\n\n| Sibling \u002F neighbor | Scope | Difference |\n|---|---|---|\n| `ra-qm-team` | ISO 13485 QMS, ISO 14971 risk, EU MDR tech docs + clinical evaluation, FDA 510(k)\u002FPMA\u002FDe Novo\u002FQSR submission | That is the **submission**; clinical-research designs the **study** beforehand |\n| `research\u002Fgrants` | NIH funding discovery + positioning | That **finds funding**; this **designs the trial** |\n| `product-team\u002Fexperiment-designer` | Live product A\u002FB hypothesis + sample size | That is a **product experiment**; this is a **clinical trial** |\n| `research-finance` (sibling) | R&D program budget + burn | That **funds** the program; this **scopes** the study |\n\n## Quick examples\n\n```bash\npython3 scripts\u002Fsample_size_estimator.py --sample\npython3 scripts\u002Fsample_size_estimator.py --design proportions --p1 0.30 --p2 0.45 --dropout 0.15\npython3 scripts\u002Fendpoint_selector.py --sample\npython3 scripts\u002Fphase_gate_scorer.py --sample --output json\n```\n\nThe sample correctly flags an unvalidated serum-cytokine surrogate (cannot be primary) and ranks PASI-75 as the PRIMARY endpoint; the phase-gate sample returns a verdict with a named owner chain.\n\n## Forcing-question library (Matt Pocock grill discipline)\n\nWalked one at a time by `\u002Fcs:grill-research-ops` or the orchestrator. Recommended answer + canon citation per question. Never bundled.\n\n1. **\"Is your primary endpoint a clinical outcome or a surrogate — and if surrogate, is it on FDA's validated table?\"**\n   Recommended: clinical outcome unless the surrogate is validated for this indication.\n   Canon: FDA Surrogate Endpoint Table; BEST (Biomarkers, EndpointS, and other Tools) glossary.\n\n2. **\"What's the minimal clinically important difference you're powering for — and where did that number come from?\"**\n   Recommended: a published or anchor-based MCID, cited; never a convenience effect size.\n   Canon: ICH E9; Cohen *Statistical Power Analysis*.\n\n3. **\"What dropout rate are you assuming, and is the sample size inflated for it?\"**\n   Recommended: inflate n by 1\u002F(1 − dropout) using a justified rate.\n   Canon: Chow, Shao & Wang; ICH E9(R1).\n\n4. **\"Single primary endpoint or multiple — and if multiple, what's the multiplicity control?\"**\n   Recommended: pre-specify alpha allocation (hierarchical \u002F Bonferroni).\n   Canon: FDA Multiple Endpoints guidance (2022).\n\n5. **\"Who is the named biostatistician \u002F medical monitor \u002F regulatory owner signing this synopsis?\"**\n   Recommended: name them now — this output is a recommendation, not a protocol.\n   Canon: ICH E6(R2) GCP roles & responsibilities.\n\nWalk depth-first. Lock 1-2 before opening 3-5. After all are answered, invoke `endpoint_selector.py` → `sample_size_estimator.py` → `phase_gate_scorer.py`.\n","# clinical-research\n\nProspective clinical study DESIGN: endpoints, sample size \u002F power, and phase-gate feasibility. Every output is an **estimate with stated assumptions** routed to a **named human owner**. This skill never gives clinical advice as fact and never substitutes for a biostatistician or regulatory affairs.\n\n## Purpose\n\nR&D clinical teams, medical monitors, and biostatistics functions live at the moment between *we-have-a-hypothesis* and *we-have-a-protocol-ready-for-submission*. This skill structures three of the hardest design decisions:\n\nThree deterministic tools:\n\n1. `sample_size_estimator.py` — Closed-form power \u002F sample-size for two-arm **means** (Cohen's d), **proportions** (normal approximation), and **survival** (Schoenfeld events). Inflates for dropout. Prints an \"ESTIMATE — confirm with a biostatistician\" banner.\n2. `endpoint_selector.py` — Scores candidate endpoints across 5 weighted dimensions (clinical relevance, measurability, regulatory acceptance, sensitivity-to-change, burden) and classifies each as **PRIMARY \u002F KEY-SECONDARY \u002F EXPLORATORY**. Penalizes unvalidated surrogate endpoints.\n3. `phase_gate_scorer.py` — Scores a study plan 0-100 across recruitment feasibility, endpoint readiness, statistical power, operational complexity, and budget fit; returns **GO \u002F GO-WITH-CONDITIONS \u002F REDESIGN \u002F NO-GO** plus the named owners who must sign.\n\n## When to use\n\nInvoke this skill when:\n\n- You are choosing a primary endpoint and need to defend it against surrogate-endpoint scrutiny.\n- You need a defensible first sample-size estimate for a protocol synopsis.\n- A study plan needs a feasibility read before a phase-gate review.\n- You are pressure-testing whether the planned enrollment is achievable given the eligible population and sites.\n\n**Do NOT use this skill to**: prepare a regulatory submission or clinical evaluation report (use `ra-qm-team`), find or position a grant (use `research\u002Fgrants`), design a live product A\u002FB experiment (use `product-team\u002Fexperiment-designer`), or replace a biostatistician's final sample-size justification.\n\n## Workflow\n\n1. **Draft the synopsis** — Fill `assets\u002Fprotocol_synopsis_template.md` (objectives, design, population, endpoints, statistical plan placeholder, owners-to-sign).\n2. **Select the endpoint** — Run `endpoint_selector.py --input endpoints.json --profile {drug|device|biologic|diagnostic|digital-therapeutic}`. Read the classification + surrogate flags. If >1 primary, plan multiplicity control.\n3. **Estimate the sample size** — Run `sample_size_estimator.py --design {means|proportions|survival} ...`. Trace the effect\u002Fdifference\u002FHR to a published or anchor-based source; inflate for dropout.\n4. **Score feasibility** — Run `phase_gate_scorer.py --input study.json --profile \u003Csame> --phase {1|2|3|4}`. Read the verdict + blockers + named owners.\n5. **Route for sign-off** — Assemble the synopsis + estimates into the gate packet. The packet is **a recommendation**; a biostatistician, medical monitor, and regulatory owner sign.\n\n## Scripts\n\n| Script | Purpose | Profiles |\n|---|---|---|\n| `scripts\u002Fsample_size_estimator.py` | Power \u002F sample-size for means, proportions, survival | n\u002Fa (design-driven) |\n| `scripts\u002Fendpoint_selector.py` | 5-dimension endpoint scoring + classification + surrogate flag | drug, device, biologic, diagnostic, digital-therapeutic |\n| `scripts\u002Fphase_gate_scorer.py` | Feasibility 0-100 + GO\u002FGO-WITH-CONDITIONS\u002FREDESIGN\u002FNO-GO + owners | drug, device, biologic, diagnostic, digital-therapeutic |\n\nAll three: stdlib-only, `--help`, `--sample`, `--output {human,json}`.\n\n## Onboarding & customization\n\nRun the onboarding questionnaire **once before you start** — it captures your defaults and named owners so every tool in this skill is pre-configured. Customization is the point: the answers actually change tool behavior.\n\n```bash\npython3 scripts\u002Fonboard.py            # interactive (also: --defaults, --set key=value, --reset)\npython3 scripts\u002Fonboard.py --show     # see the questions + current effective config\n```\n\nAnswers are saved to `~\u002F.config\u002Fresearch-ops\u002Fclinical-research.json` (global) or `.\u002F.research-ops\u002Fclinical-research.json` (`--scope project`) and are read automatically by `config_loader.py`. They set the default development-area **profile**, default **alpha \u002F power \u002F dropout**, and the named **biostatistician \u002F medical monitor \u002F regulatory owner** printed on outputs. CLI flags always override saved config; `RESEARCH_OPS_NO_CONFIG=1` ignores it entirely.\n\n**The seven questions:** development area · alpha · power · dropout · biostatistician · medical monitor · regulatory owner.\n\n## Optimize with autoresearch (opt-in)\n\nThis skill ships an **isolated, opt-in** bridge to `engineering\u002Fautoresearch-agent`. Only when you ask to \"optimize\" \u002F \"run a loop\" does an autoresearch experiment iteratively improve a study plan against this skill's own feasibility score. `scripts\u002Far_evaluator.py` is the ground-truth evaluator; it prints `feasibility_composite: \u003C0-100>` (higher is better).\n\n```bash\n\u002Far:setup --domain custom --name trial-feasibility \\\n  --target study.json \\\n  --eval \"python3 ar_evaluator.py --target study.json\" \\\n  --metric feasibility_composite --direction higher\n\u002Far:loop custom\u002Ftrial-feasibility\n```\n\nIsolated: no hard dependency — autoresearch runs only on demand, and the loop edits `study.json`, never the evaluator (locked ground truth).\n\n## References\n\n- `references\u002Fstudy_design_canon.md` — ICH E8(R1) general considerations; ICH E9 + E9(R1) estimand addendum; CONSORT 2010; SPIRIT 2013; FDA Multiple Endpoints guidance (2022).\n- `references\u002Fendpoint_and_power.md` — Cohen *Statistical Power Analysis*; Schoenfeld (1983) survival sample size; FDA Surrogate Endpoint Table \u002F BEST glossary; FDA PRO guidance (2009); Chow, Shao & Wang *Sample Size Calculations in Clinical Research*.\n- `references\u002Ftrial_operations.md` — ICH E6(R2\u002FR3) GCP; TransCelerate risk-based monitoring; FDA RBM guidance; CTTI recruitment best practices; site-feasibility scoring literature.\n\n## Assumptions\n\n- Sample-size formulas use normal approximations with a built-in z-table. They are first-pass **estimates**; a biostatistician produces the final justification (and may use simulation, adaptive designs, or exact methods).\n- The endpoint scorer applies *customary* regulatory priors per development area via `--profile`. Company- or indication-specific precedent overrides the prior.\n- The phase-gate scorer bakes in a profile cost-per-patient benchmark; pass a real budget to override the default.\n- An unvalidated surrogate cannot anchor a PRIMARY endpoint — the scorer enforces this with a penalty.\n\n## Anti-patterns\n\n- **Presenting a power estimate as fact.** Every output is an estimate with a named owner who must sign.\n- **Powering for a convenience effect size.** The effect must trace to a published or anchor-based MCID, not to the n you can afford.\n- **Anchoring a primary on an unvalidated surrogate.** Surrogate endpoints need validation evidence for the indication.\n- **Ignoring multiplicity.** More than one primary endpoint requires pre-specified alpha allocation.\n- **Skipping dropout inflation.** Raw n undersizes the study; inflate by 1\u002F(1 − dropout).\n\n## Distinct from\n\n| Sibling \u002F neighbor | Scope | Difference |\n|---|---|---|\n| `ra-qm-team` | ISO 13485 QMS, ISO 14971 risk, EU MDR tech docs + clinical evaluation, FDA 510(k)\u002FPMA\u002FDe Novo\u002FQSR submission | That is the **submission**; clinical-research designs the **study** beforehand |\n| `research\u002Fgrants` | NIH funding discovery + positioning | That **finds funding**; this **designs the trial** |\n| `product-team\u002Fexperiment-designer` | Live product A\u002FB hypothesis + sample size | That is a **product experiment**; this is a **clinical trial** |\n| `research-finance` (sibling) | R&D program budget + burn | That **funds** the program; this **scopes** the study |\n\n## Quick examples\n\n```bash\npython3 scripts\u002Fsample_size_estimator.py --sample\npython3 scripts\u002Fsample_size_estimator.py --design proportions --p1 0.30 --p2 0.45 --dropout 0.15\npython3 scripts\u002Fendpoint_selector.py --sample\npython3 scripts\u002Fphase_gate_scorer.py --sample --output json\n```\n\nThe sample correctly flags an unvalidated serum-cytokine surrogate (cannot be primary) and ranks PASI-75 as the PRIMARY endpoint; the phase-gate sample returns a verdict with a named owner chain.\n\n## Forcing-question library (Matt Pocock grill discipline)\n\nWalked one at a time by `\u002Fcs:grill-research-ops` or the orchestrator. Recommended answer + canon citation per question. Never bundled.\n\n1. **\"Is your primary endpoint a clinical outcome or a surrogate — and if surrogate, is it on FDA's validated table?\"**\n   Recommended: clinical outcome unless the surrogate is validated for this indication.\n   Canon: FDA Surrogate Endpoint Table; BEST (Biomarkers, EndpointS, and other Tools) glossary.\n\n2. **\"What's the minimal clinically important difference you're powering for — and where did that number come from?\"**\n   Recommended: a published or anchor-based MCID, cited; never a convenience effect size.\n   Canon: ICH E9; Cohen *Statistical Power Analysis*.\n\n3. **\"What dropout rate are you assuming, and is the sample size inflated for it?\"**\n   Recommended: inflate n by 1\u002F(1 − dropout) using a justified rate.\n   Canon: Chow, Shao & Wang; ICH E9(R1).\n\n4. **\"Single primary endpoint or multiple — and if multiple, what's the multiplicity control?\"**\n   Recommended: pre-specify alpha allocation (hierarchical \u002F Bonferroni).\n   Canon: FDA Multiple Endpoints guidance (2022).\n\n5. **\"Who is the named biostatistician \u002F medical monitor \u002F regulatory owner signing this synopsis?\"**\n   Recommended: name them now — this output is a recommendation, not a protocol.\n   Canon: ICH E6(R2) GCP roles & responsibilities.\n\nWalk depth-first. Lock 1-2 before opening 3-5. After all are answered, invoke `endpoint_selector.py` → `sample_size_estimator.py` → `phase_gate_scorer.py`.\n",{"name":5,"tags":24,"author":32,"license":15,"version":33,"description":7,"compatible_tools":34},[25,5,26,27,28,29,30,31],"research-ops","study-design","endpoint","sample-size","power","phase-gate","biostatistics","claude-code-skills","2.9.0",[35,36,37,38,39,40],"claude-code","codex-cli","cursor","antigravity","opencode","gemini-cli","main","456c0680145b74fe0168cc63541f08eda89e53c0","claude-skills\u002F.vibe\u002Fskills\u002Fclaude-skills\u002Fresearch-ops\u002Fclinical-research","https:\u002F\u002Fgithub.com\u002Fazhri1990\u002Fproject-genesis","https:\u002F\u002Fgithub.com\u002Fazhri1990","2026-09-27 20:56:28",{"source":8,"skillName":5,"commands":48,"prompt":58,"zipAvailable":59},[49,52,55],{"tool":50,"command":51},"npx","npx skills add azhri1990\u002Fproject-genesis --skill clinical-research",{"tool":53,"command":54},"bunx","bunx skills add azhri1990\u002Fproject-genesis --skill clinical-research",{"tool":56,"command":57},"pnpm","pnpm dlx skills add azhri1990\u002Fproject-genesis --skill clinical-research","安装技能，技能地址：https:\u002F\u002Fgithub.com\u002Fazhri1990\u002Fproject-genesis\u002Fblob\u002Fmain\u002Fclaude-skills\u002F.vibe\u002Fskills\u002Fclaude-skills\u002Fresearch-ops\u002Fclinical-research\u002FSKILL.md",true,[61,67,73,77,81,87,91,95,99,103],{"path":62,"resourceType":63,"resourceTypeDesc":64,"sizeBytes":65,"sourceHtmlUrl":66},"assets\u002Fprotocol_synopsis_template.md","ASSET","资产文件",1950,"https:\u002F\u002Fgithub.com\u002Fazhri1990\u002Fproject-genesis\u002Fblob\u002Fmain\u002Fclaude-skills\u002F.vibe\u002Fskills\u002Fclaude-skills\u002Fresearch-ops\u002Fclinical-research\u002Fassets\u002Fprotocol_synopsis_template.md",{"path":68,"resourceType":69,"resourceTypeDesc":70,"sizeBytes":71,"sourceHtmlUrl":72},"references\u002Fendpoint_and_power.md","REFERENCE","参考文档",3110,"https:\u002F\u002Fgithub.com\u002Fazhri1990\u002Fproject-genesis\u002Fblob\u002Fmain\u002Fclaude-skills\u002F.vibe\u002Fskills\u002Fclaude-skills\u002Fresearch-ops\u002Fclinical-research\u002Freferences\u002Fendpoint_and_power.md",{"path":74,"resourceType":69,"resourceTypeDesc":70,"sizeBytes":75,"sourceHtmlUrl":76},"references\u002Fstudy_design_canon.md",3078,"https:\u002F\u002Fgithub.com\u002Fazhri1990\u002Fproject-genesis\u002Fblob\u002Fmain\u002Fclaude-skills\u002F.vibe\u002Fskills\u002Fclaude-skills\u002Fresearch-ops\u002Fclinical-research\u002Freferences\u002Fstudy_design_canon.md",{"path":78,"resourceType":69,"resourceTypeDesc":70,"sizeBytes":79,"sourceHtmlUrl":80},"references\u002Ftrial_operations.md",2957,"https:\u002F\u002Fgithub.com\u002Fazhri1990\u002Fproject-genesis\u002Fblob\u002Fmain\u002Fclaude-skills\u002F.vibe\u002Fskills\u002Fclaude-skills\u002Fresearch-ops\u002Fclinical-research\u002Freferences\u002Ftrial_operations.md",{"path":82,"resourceType":83,"resourceTypeDesc":84,"sizeBytes":85,"sourceHtmlUrl":86},"scripts\u002Far_evaluator.py","SCRIPT","脚本",2754,"https:\u002F\u002Fgithub.com\u002Fazhri1990\u002Fproject-genesis\u002Fblob\u002Fmain\u002Fclaude-skills\u002F.vibe\u002Fskills\u002Fclaude-skills\u002Fresearch-ops\u002Fclinical-research\u002Fscripts\u002Far_evaluator.py",{"path":88,"resourceType":83,"resourceTypeDesc":84,"sizeBytes":89,"sourceHtmlUrl":90},"scripts\u002Fconfig_loader.py",4101,"https:\u002F\u002Fgithub.com\u002Fazhri1990\u002Fproject-genesis\u002Fblob\u002Fmain\u002Fclaude-skills\u002F.vibe\u002Fskills\u002Fclaude-skills\u002Fresearch-ops\u002Fclinical-research\u002Fscripts\u002Fconfig_loader.py",{"path":92,"resourceType":83,"resourceTypeDesc":84,"sizeBytes":93,"sourceHtmlUrl":94},"scripts\u002Fendpoint_selector.py",6783,"https:\u002F\u002Fgithub.com\u002Fazhri1990\u002Fproject-genesis\u002Fblob\u002Fmain\u002Fclaude-skills\u002F.vibe\u002Fskills\u002Fclaude-skills\u002Fresearch-ops\u002Fclinical-research\u002Fscripts\u002Fendpoint_selector.py",{"path":96,"resourceType":83,"resourceTypeDesc":84,"sizeBytes":97,"sourceHtmlUrl":98},"scripts\u002Fonboard.py",5551,"https:\u002F\u002Fgithub.com\u002Fazhri1990\u002Fproject-genesis\u002Fblob\u002Fmain\u002Fclaude-skills\u002F.vibe\u002Fskills\u002Fclaude-skills\u002Fresearch-ops\u002Fclinical-research\u002Fscripts\u002Fonboard.py",{"path":100,"resourceType":83,"resourceTypeDesc":84,"sizeBytes":101,"sourceHtmlUrl":102},"scripts\u002Fphase_gate_scorer.py",9390,"https:\u002F\u002Fgithub.com\u002Fazhri1990\u002Fproject-genesis\u002Fblob\u002Fmain\u002Fclaude-skills\u002F.vibe\u002Fskills\u002Fclaude-skills\u002Fresearch-ops\u002Fclinical-research\u002Fscripts\u002Fphase_gate_scorer.py",{"path":104,"resourceType":83,"resourceTypeDesc":84,"sizeBytes":105,"sourceHtmlUrl":106},"scripts\u002Fsample_size_estimator.py",8739,"https:\u002F\u002Fgithub.com\u002Fazhri1990\u002Fproject-genesis\u002Fblob\u002Fmain\u002Fclaude-skills\u002F.vibe\u002Fskills\u002Fclaude-skills\u002Fresearch-ops\u002Fclinical-research\u002Fscripts\u002Fsample_size_estimator.py",[108,115,122,129,136,143],{"skillNo":109,"name":110,"nameZh":6,"description":111,"descriptionZh":6,"repositoryFullName":8,"ownerLogin":9,"ownerAvatarUrl":10,"ownerAccountNo":11,"ownerDisplayName":12,"repositoryNo":13,"starsCount":14,"licenseSpdxId":15,"licenseFileUrl":6,"sourceHtmlUrl":112,"categories":113,"keywords":114,"publishedAt":19},"01M7C0EZY9FK6JW3YAC7CN17KY","syllabus","Generates a curated supplementary reading list from any course syllabus using Consensus academic search. Grill-me intake (syllabus input format + course audience + year range) plus a grouping forcing-options checkpoint before any search runs — so the reading list matches the course's level and recency need. Parses the syllabus to extract topics and learning outcomes, searches Consensus for recent peer-reviewed papers per topic, and produces a professionally formatted .docx with clickable Consensus links, plain-language summaries calibrated to audience level, and Bloom-higher-order discussion questions tied to course learning goals. Use when the user uploads a syllabus, course outline, or curriculum document and wants supplementary readings (e.g., 'create a reading list from this syllabus', 'find recent papers for my course') — even casual mentions with a syllabus attached should trigger this skill.","https:\u002F\u002Fgithub.com\u002Fazhri1990\u002Fproject-genesis\u002Fblob\u002Fmain\u002Fclaude-skills\u002Fresearch\u002Fsyllabus\u002Fskills\u002Fsyllabus\u002FSKILL.md",[],[],{"skillNo":116,"name":117,"nameZh":6,"description":118,"descriptionZh":6,"repositoryFullName":8,"ownerLogin":9,"ownerAvatarUrl":10,"ownerAccountNo":11,"ownerDisplayName":12,"repositoryNo":13,"starsCount":14,"licenseSpdxId":15,"licenseFileUrl":6,"sourceHtmlUrl":119,"categories":120,"keywords":121,"publishedAt":19},"01M7C0EA12FWRZTMG0N23HV68M","pulse","Multi-source recency research skill that takes the pulse of any topic across Reddit, Hacker News, the open web, and optionally X\u002FTwitter within a configurable recent window (default 30 days). Forcing intake clarifies topic specificity, angle (trend\u002Fsentiment\u002Fproblems\u002Fopportunities\u002Fcomparison), time window, and platform scope before searching. Returns a synthesized briefing with citations, engagement metrics, and cross-platform pattern analysis. Use when the user requests multi-source recency intelligence on a topic (e.g., 'pulse on [topic]', 'what's happening with [topic]', 'what are people saying about [topic]', 'current conversation about [topic]', 'take the pulse of [topic]', 'trending: [topic]', 'find me info on [topic]'), and for competitor research, trend discovery, tool comparisons, and audience sentiment analysis.","https:\u002F\u002Fgithub.com\u002Fazhri1990\u002Fproject-genesis\u002Fblob\u002Fmain\u002Fclaude-skills\u002Fresearch\u002Fpulse\u002Fskills\u002Fpulse\u002FSKILL.md",[],[],{"skillNo":123,"name":124,"nameZh":6,"description":125,"descriptionZh":6,"repositoryFullName":8,"ownerLogin":9,"ownerAvatarUrl":10,"ownerAccountNo":11,"ownerDisplayName":12,"repositoryNo":13,"starsCount":14,"licenseSpdxId":15,"licenseFileUrl":6,"sourceHtmlUrl":126,"categories":127,"keywords":128,"publishedAt":19},"01M7C0DXEHJKMKTB4N6B7MS4BT","patent","Patent prior-art and landscape intelligence skill — not generic patent help. Commits to one of five sub-use-cases via forcing intake (novelty search \u002F freedom-to-operate \u002F competitive landscape \u002F acquisition diligence \u002F litigation prior-art) before any search runs. Searches Google Patents, Espacenet, USPTO, and optionally Lens.org for citation-graph signals. Output is an editable Word document (.docx) with verdict, ranked closest art (claim-text extracted), CPC-class-aware landscape, family-resolved hits, geographic coverage, FTO flags where applicable, strategy recommendations, and full audit log. Use when the user asks for patent searching or analysis (e.g., 'prior art search for [invention]', 'freedom to operate analysis for [product]'). Produces search signal, not legal advice — always recommends consulting a patent attorney before filing or licensing decisions. Trademark, copyright, and trade-secret questions are out of scope.","https:\u002F\u002Fgithub.com\u002Fazhri1990\u002Fproject-genesis\u002Fblob\u002Fmain\u002Fclaude-skills\u002Fresearch\u002Fpatent\u002Fskills\u002Fpatent\u002FSKILL.md",[],[],{"skillNo":130,"name":131,"nameZh":6,"description":132,"descriptionZh":6,"repositoryFullName":8,"ownerLogin":9,"ownerAvatarUrl":10,"ownerAccountNo":11,"ownerDisplayName":12,"repositoryNo":13,"starsCount":14,"licenseSpdxId":15,"licenseFileUrl":6,"sourceHtmlUrl":133,"categories":134,"keywords":135,"publishedAt":19},"01M7C0DJM5ECEKZXTQA9G6YHQZ","notebooklm","Browser automation skill for controlling Google's NotebookLM. Use when the user wants anything done in NotebookLM (e.g., 'open NotebookLM', 'check my [name] notebook', 'ask my notebook about X', 'add [source] to NotebookLM', 'generate a Video Overview from my notebook', 'use NotebookLM Studio'). Handles reading and querying notebooks, adding sources (URLs, text, files, YouTube links, synthesized content), generating Studio outputs (Audio\u002FVideo Overviews, Mind Maps, Reports incl. Briefing Doc\u002FStudy Guide\u002FFAQ, Flashcards, Quiz, slide decks, infographics — discover the exact set from the live Studio panel; the UI evolves fast), and creating new notebooks. Requires browser automation environment — fails gracefully when unavailable.","https:\u002F\u002Fgithub.com\u002Fazhri1990\u002Fproject-genesis\u002Fblob\u002Fmain\u002Fclaude-skills\u002Fresearch\u002Fnotebooklm\u002Fskills\u002Fnotebooklm\u002FSKILL.md",[],[],{"skillNo":137,"name":138,"nameZh":6,"description":139,"descriptionZh":6,"repositoryFullName":8,"ownerLogin":9,"ownerAvatarUrl":10,"ownerAccountNo":11,"ownerDisplayName":12,"repositoryNo":13,"starsCount":14,"licenseSpdxId":15,"licenseFileUrl":6,"sourceHtmlUrl":140,"categories":141,"keywords":142,"publishedAt":19},"01M7C0D304Z7YX7J25R42N6W2T","litreview","Academic literature orientation skill that searches papers via free keyless APIs (PubMed E-utilities + OpenAlex) by default — with the Consensus MCP as an optional enhancement lane when connected — builds a strategic search plan using PICO (default) or SPIDER \u002F Decomposition \u002F hybrid as fallbacks, and synthesizes findings into a formatted Word (.docx) research guide. Grill-me intake (research question specificity + framework hint + tentative depth) before the recon search; a second forcing checkpoint after Phase 2 confirms framework + sub-areas + depth before searches consume budget. Configurable depth (5\u002F10\u002F20 queries) controls coverage vs. speed. Output is a 'launching pad' — an orientation guide that lets a researcher dive in confidently, not a finished review. Use when the user starts literature-oriented research (e.g., 'litreview on [topic]', 'literature review on [topic]', 'I'm starting a literature review on X', 'I'm writing a paper on X', 'help me research X', 'I'm doing research on X', 'can you help me research X'). Do NOT use for single one-off paper searches wanting a quick list — that's a plain PubMed\u002FOpenAlex (or Consensus) query.","https:\u002F\u002Fgithub.com\u002Fazhri1990\u002Fproject-genesis\u002Fblob\u002Fmain\u002Fclaude-skills\u002Fresearch\u002Flitreview\u002Fskills\u002Flitreview\u002FSKILL.md",[],[],{"skillNo":144,"name":145,"nameZh":6,"description":146,"descriptionZh":6,"repositoryFullName":8,"ownerLogin":9,"ownerAvatarUrl":10,"ownerAccountNo":11,"ownerDisplayName":12,"repositoryNo":13,"starsCount":14,"licenseSpdxId":15,"licenseFileUrl":6,"sourceHtmlUrl":147,"categories":148,"keywords":149,"publishedAt":19},"01M7C0CP1419VDF6SGCDY6ZRZV","grants","NIH grant research skill for clinical researchers. Grill-me intake (research idea + career stage + preliminary data + environment + submission posture + known institute targets) locks down the funding strategy before any search runs. Runs a 5-facet Consensus positioning analysis (with draft Significance\u002FInnovation language), maps the research to the right NIH institutes and study sections via RePORTER, finds NOSIs and funded overlap, and produces an editable Word document (.docx) with budget\u002Fscope-aware mechanism recommendations, submission timelines, and a mandatory program officer recommendation. Use when the user asks about research funding or makes any grant-related request (e.g., 'grants for [topic]', 'find grants for my research idea', 'what grants match my research', 'help me find NIH funding', 'grant opportunities for my research'). NIH-only scope — non-NIH funders (PCORI, DOD CDMRP, VA, foundations) are out of scope and flagged at intake.","https:\u002F\u002Fgithub.com\u002Fazhri1990\u002Fproject-genesis\u002Fblob\u002Fmain\u002Fclaude-skills\u002Fresearch\u002Fgrants\u002Fskills\u002Fgrants\u002FSKILL.md",[],[]]